Get your free ETF data sample from our comprehensive offerings. Start your free trial→
Help us improve your experience. Please confirm your investor type:
The ETF Industry Is Evolving Fast
From AI infrastructure to active strategies, the ETF landscape is shifting. Share your perspective in the 7th Annual Global ETF Survey.
ETFs with exposure to Innovent Biologics, Inc. (1801)
KraneShares MSCI All China Health Care Index ETF - USD This ETF provides exposure to Large and Mid-Cap Chinese Health Care Equities | 8.60% | +0.44% | -6.93% | +€19K | +€1.2M | €64M | 0.79% | |
|---|---|---|---|---|---|---|---|---|
4.88% | +5.42% | +1.56% | €0 | +€1.3M | €3.8M | 0.59% | Not rated | |
3.92% | +3.78% | -5.57% | +€2.5M | +€12M | €47M | 0.59% | Not rated | |
2.18% | -16.12% | -26.12% | €0 | €0 | €3.8M | 1% | Not rated | |
UBS Solactive China Technology UCITS ETF A-acc - EUR Hedged This ETF provides exposure to Chinese Equities Share class Acc EUR Hedged | 2.10% | -6.73% | -13.14% | -€36M | +€2.9M | €112M | 0.5% | |
UBS Solactive China Technology UCITS ETF A-acc - USD This ETF provides exposure to Chinese Equities Share class Acc USD | 2.10% | -6.66% | -12.88% | -€6.6M | -€326M | €215M | 0.47% | |
UBS Solactive China Technology UCITS ETF - CHF Hedged This ETF provides exposure to Chinese Equities Share class Acc CHF Hedged | 2.10% | -6.97% | -8.61% | +€1.2M | +€1.6M | €1.5M | 0.5% | Not rated |
1.96% | +0.76% | +1.93% | €0 | €0 | €20M | 0.79% | Not rated | |
Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C - USD This ETF provides exposure to Other Equities | 1.86% | +13.10% | +9.81% | €0 | +€2.1M | €8.9M | 0.25% | |
Amundi MSCI China ESG Selection Extra UCITS ETF Dist - EUR This ETF provides exposure to Large and Mid-Cap Chinese Equities Share class Dist EUR | 1.12% | -7.44% | -13.22% | -€3.1M | -€41M | €86M | 0.65% | Not rated |
About Trackinsight
Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.
Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.
In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.
This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.
Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.
More about TrackinsightETF TOOLS
PLATFORM
ETF NEWS & RESEARCH
Privacy policy | Cookie policy | | Terms of use | Imprint
